ESMO: European Society for Medical Oncology

  1. The approval is based on two randomised, controlled trials, CALGB 100104 and IFM 2005-02 
  2. Evidence-based recommendations on using immunohistochemistry or microsatellite instability testing to guide further testing for Lynch syndrome 
  3. Global HOPE will build long-term capacity to treat and improve the prognosis in this setting in southern and eastern Africa
  4. Death rates from cancer in the European Union (EU) are falling faster in men than in women, according to the latest predictions for European cancer deaths in 2017, published in the leading cancer journal Annals of Oncology
  5. Hypothesis generating study in first line mRCC shows that two drugs can be combined with a manageable safety profile and encouraging efficacy